Eyepoint Goldman Sachs June 10 2025 · page 21 of 29
The chart compares DURAVYU 2.7mg, DURAVYU 1.3mg, and Aflibercept 2mg. The final values at Week 24 are highlighted in a box.
Consulting deck · data_table · quantify_impact · balanced density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 disclaimer 1/1 legend 1/1 title 1/1
Components 4
line disclaimer legend action-title
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.